Arm Holdings takeover: has Nvidia had its chips?
The takeover of Britain’s semiconductor group Arm Holdings by its US rival Nvidia could be running into the sand, says Matthew Partridge.

The $40bn acquisition of British semiconductor manufacturer Arm Holdings by America’s Nvidia has been left hanging in the balance, says Amy Thomson on Bloomberg. The culture secretary, Oliver Dowden, says the government may intervene to prevent the tie-up. Dowden has ordered the Competition and Markets Authority (CMA), which is already looking at the impact on competition, to investigate the national security aspects of the deal too.
He notes that the semiconductors are not only “fundamental” to a “wide range of technologies”, including those in defence and national security, but also “underpin the UK’s critical national infrastructure”. Nvidia’s ownership could bring Arm under the “control of powerful US national security laws” that could one day be “used against Britain’s interests”, says Hannah Boland in The Daily Telegraph.
The next US tech monopoly
National security concerns aren’t the only reason why some are opposing the deal, says Mark Sweney in The Guardian. Hermann Hauser, Arm’s original co-founder, has argued that it would be “an absolute disaster for Cambridge, the UK and Europe”, as Nvidia would inevitably decide to relocate Arm to the US, leading to lost jobs.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
More importantly, being owned by Nvidia would also destroy Arm’s “even-handed” model of licensing its chip designs to a wide range of technology companies, including Apple, Samsung and Qualcomm, turning the combined company into “the next US tech monopoly alongside companies such as Google, Facebook and Amazon”.
Even if the British government eventually gives the deal its blessing, it still might not go ahead, says Gina Chon on Breakingviews. Thanks to complaints from Microsoft and Google, the US Federal Trade Commission (FTC) also has the deal under “extended review” on competition grounds. An “unprecedented” semiconductor shortage is already causing the FTC review to go on for much longer than originally anticipated and giving it “more reason to hit pause”. The “global regulatory pile-on” means that Nvidia and Arm “must prepare for regulators to chip away further”.
Although Nvidia continues to maintain that it “can score the necessary government approvals to close the Arm deal”, its behaviour is making this harder, says Dan Gallagher in The Wall Street Journal. Last week Nvidia announced the launch of a new central processing unit, or CPU, called Grace. It is designed for use in data centres, which would effectively compete for the data-centre slots mostly occupied by chips from Intel and Advanced Micro Devices (AMD). While the move boosted Nvidia’s share price, the fact that both Grace and the current offerings from AMD and Intel use Arm technology makes it easy to see how merging Nvidia and Arm could reduce competition.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Tesco braces for supermarket price war with rival Asda
Tesco, Britain’s biggest grocer, has opted to cut its prices more quickly to prevent Asda grabbing market share
By Dr Matthew Partridge
-
Supersonic travel: How China could 'leapfrog' US and Europe's commercial aviation industry
Opinion Innovation in commercial aviation has been stuck for 60 years. A commercial supersonic jet might be back on the market soon, but will China get there first?
By Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves